Vertex Pharmaceuticals (VRTX) Stock Chart & Stock Price History $407.11 +1.35 (+0.33%) As of 01/3/2025 05:45 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Vertex Pharmaceuticals Stock Price Performance 5 Day Performance+1.94%1 Month Performance-12.26%3 Month Performance-10.59%6 Month Performance-13.43%Year-To-Date Performance+1.10%1 Year Performance-2.17% Receive VRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Stock Chart for Saturday, January, 4, 2025 VRTX Chart by TradingView Vertex Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/03/2025$405.76$407.11+0.33%$411.65$406.401.09 million shs$104.84 billion01/02/2025$402.70$405.76+0.76%$409.60$402.721.28 million shs$104.49 billion01/01/2025$402.70$402.70$404.99$399.631.05 million shs$103.71 billion12/31/2024$399.35$402.70+0.84%$404.99$399.631.05 million shs$103.71 billion12/30/2024$408.76$399.35-2.30%$407.35$399.061.45 million shs$102.84 billion12/27/2024$410.65$408.76-0.46%$410.98$404.491.37 million shs$105.27 billion Get the Latest News and Ratings for VRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/26/2024$408.18$410.65+0.61%$411.29$406.021.19 million shs$105.75 billion12/25/2024$408.18$408.18$410.68$401.271.47 million shs$105.12 billion12/24/2024$405.27$408.18+0.72%$410.68$401.271.47 million shs$105.12 billion12/23/2024$397.27$405.27+2.01%$405.93$390.922.20 million shs$104.37 billion12/20/2024$396.64$397.27+0.16%$401.31$386.496.20 million shs$102.31 billion12/19/2024$447.50$396.64-11.37%$404.04$377.858.21 million shs$102.15 billion12/18/2024$469.24$447.50-4.63%$471.05$445.871.76 million shs$115.24 billion12/17/2024$468.09$469.24+0.25%$474.19$465.621.30 million shs$120.84 billion12/16/2024$463.73$468.09+0.94%$470.08$462.131.51 million shs$120.55 billion12/13/2024$464.12$463.73-0.08%$466.66$459.791.10 million shs$119.42 billion12/12/2024$468.29$464.12-0.89%$470.25$460.05956,574 shs$119.52 billion12/11/2024$469.22$468.29-0.20%$472.33$460.891.04 million shs$120.60 billion12/10/2024$473.98$469.22-1.00%$476.46$465.12864,875 shs$120.84 billion12/09/2024$462.10$473.98+2.57%$476.02$467.001.26 million shs$122.06 billion12/06/2024$459.92$462.10+0.47%$465.90$456.861.12 million shs$119.00 billion12/05/2024$463.98$459.92-0.88%$467.06$457.961.18 million shs$118.44 billion12/04/2024$456.97$463.98+1.53%$464.87$450.001.22 million shs$119.49 billion12/03/2024$465.73$456.97-1.88%$468.51$455.011.18 million shs$117.68 billion Related Companies Amgen Stock Price Chart Gilead Sciences Stock Price Chart Regeneron Pharmaceuticals Stock Price Chart Alnylam Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart Neurocrine Biosciences Stock Price Chart Incyte Stock Price Chart BioMarin Pharmaceutical Stock Price Chart Exact Sciences Stock Price Chart Receive VRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRTX) was last updated on 1/4/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
